Filing Details

Accession Number:
0001209191-14-075097
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-12 18:47:14
Reporting Period:
2014-12-10
Filing Date:
2014-12-12
Accepted Time:
2014-12-12 18:47:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1411158 Anacor Pharmaceuticals Inc. ANAC Pharmaceutical Preparations (2834) 251854385
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1571819 Lee Zane C/O Anacor Pharmaceuticals, Inc.
1020 East Meadow Circle
Palo Alto CA 94303
Svp And Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-12-10 4,800 $5.00 11,800 No 4 M Direct
Common Stock Disposition 2014-12-10 4,800 $36.09 7,000 No 4 S Direct
Common Stock Acquisiton 2014-12-11 100 $5.00 7,100 No 4 M Direct
Common Stock Disposition 2014-12-11 100 $36.00 7,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2014-12-10 4,800 $5.00 4,800 $5.00
Common Stock Stock Option (right to buy) Disposition 2014-12-11 100 $5.00 100 $5.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,199 2019-03-26 No 4 M Direct
7,099 2019-03-26 No 4 M Direct
Footnotes
  1. Includes 1,000 shares purchased on July 31, 2014 pursuant to the Issuer's ESPP.
  2. The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $36.005 to $36.245, inclusive.
  3. This option is fully vested and exercisable.